Dawid Bodusz
Papers
1
Total Citations
7
H-Index
1
About
Dawid Bodusz is a clinical researcher specializing in radiation oncology, with a focused interest in stereotactic radiotherapy for prostate cancer. His most cited work, a 2015 prospective study on the acute toxicity of robotic ultrahypofractionated radiotherapy using the CyberKnife™ system, evaluated 132 men with low- and intermediate-risk prostate cancer. This research demonstrated that delivering a total dose of 36.25 Gy in five fractions is a feasible and well-tolerated approach, contributing valuable safety data to the growing field of hypofractionated treatment protocols. With 7 citations, this study has informed clinical practice by highlighting the reduced toxicity profile of this non-invasive technique. Bodusz’s work sits at the intersection of precision medicine and oncology, aiming to improve patient outcomes through shorter, more targeted radiation courses. His contributions underscore the potential of advanced radiotherapy platforms to minimize side effects while maintaining efficacy, making him a notable figure in the evolution of prostate cancer management.
Research Focus
Key Achievements
Top Papers
- 1